Sarah Viehbeck

Science & Technology Strategy - promotion of enhanced measures to increase research in science and technology Indirect Costs Program - support for enhanced provisions Increased support for commercialization of university research results Federal Research Granting Councils and agencies funding of research, academic pursuits, and publication or dissemination Centres of Excellence - promotion of increased funding for establishment of Centres of Excellence in research Budget - promotion of increased funding of research and academic pursuites

Advocacy for investment in the Canadian energy sector. Advocacy to advance international collaboration to support sustainable development. Advocacy to support funding for higher education programs and research initiatives in the health sciences. Advocacy to advance Canadian leadership in key areas through long-term support for major research facilities and initiatives. Advocacy related to policies that impact international students. Advocacy to represent university interests in the allocation of land. International collaboration to support the reputation of Canadian universities abroad. Advocacy to advance Canadian leadership in priority areas, including artificial intelligence and defence, to support world-class research and the attraction and retention of top talent, including, but not limited to, specific calls for proposals. Regulations related to visitor visas to support international engagement. Support in principle for high-speed rail along the Québec–Toronto corridor and advocacy for the inclusion of a stop in Kingston. Advocacy to secure support in the budget for post-secondary education, research, innovation, and science. Advocacy to increase support for university research, including research funding and granting programs administered by the tri-agencies (SSHRC, NSERC, CIHR) and other departments and agencies. Advocacy to enhance support for university research mobilization and commercialization. Timeliness of decisions regarding Temporary Residence Visas in the recruiting of international faculty. Student assistance and financial support for higher education, sources of funding to be determined. Science and Technology Policy - Operating funding for major scientific installations and equipment from the Canada Foundation for Innovation. Regulations related to the provision of immigration advice (under section 91 of the Immigration and Refugee Protection Act) Military and Veteran's Health - seeking support for the national research program of the Canadian Institute for Military and Veteran Health through Veterans Affairs Canada and the Department of National Defence. Maintenance and growth in funding for investigator-driven grants from tricouncils. Indirect Costs of Research Program - increase in support to levels of international peers, source of funding to be determined. Funding for infrastructure to support advanced research and teaching Funding for health sciences initiatives - Obtain federal funding to extend the value chain of cancer clinical trails in Canada. Sources of funding to be determined. FedDev Ontario Applied Research and Commercialization (ARC) initiative to support applied research and commercialization for SME-University partnerships

Communicating with government officials about improved health outcomes, including, but not limited to (i) expanding equitable access to innovative therapies, diagnostics and vaccines, (ii) promoting pricing reform, (iii) enhancing health security, including via the Health Emergency Readiness Canada ("HERC") Agency and (iv) promoting regulatory efficiency and modernization, including through the Order Providing for Reliance on Decisions of, or Documents Produced by, Foreign Regulatory Authorities in Respect of Certain Drugs. Communicating with government officials about the implementation and expansion of the national pharmacare program, including as it relates to the Pharmacare Act, S.C. 2024, c. 24. Communicating with government officials about the implementation, renewal and expansion of the "National Strategy for Drugs for Rare Diseases" (2023). Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy. Communicating with government officials about international trade agreements, including the Canada-United States-Mexico Agreement (CUSMA), formerly known as the North American Free Trade Agreement (NAFTA), more specifically as it relates to trade in the life sciences and biopharmaceutical sectors. Communicating with government officials about international trade, more specifically tariffs and non-tariff trade barriers affecting the life sciences and biopharmaceutical sectors. Communicating with government officials about regulations, guidelines, reviews, references and reporting requirements issued by and/or related to the Patented Medicine Prices Review Board ("PMPRB"). Communicating with government officials about regulations related to patented medicines, including the "Patented Medicines (Notice of Compliance) Regulations" (SOR/93-133) under the Patent Act. Communicating with government officials about a national pharmaceutical strategy, more specifically as it relates to (i) enhanced access to orphan drugs and (i) incentives for the development of rare disorder treatments. Communicating with government officials about the Food and Drugs Act, including about (i) the approval framework for drug products, such as subsequent entry biologics (also known as biosimilars), (ii) export and cross-border trade restrictions for drug products, (iii) data exclusivity for drug products, (iv) approvals (and subsequent reviews) for new drug submissions, and (v) post-market surveillance of drug products. Communicating with government officials about federal healthcare plans and benefits. Communicating with government officials about the Government of Canada's "Biomanufacturing and Life Sciences Strategy" (2021). Communicating with government officials about programs, reports, reviews and policies issued by or related to Canada's Drug Agency (formerly known as the Canadian Agency for Drugs and Technologies in Health). Communicating with government officials about the pan-Canadian Health Data Strategy, more specifically about health data foundations.

CCA was established by the federal government in 2005 to provide assessments of evidence on policy priorities important to the Government of Canada and Canadians. CCA's interactions with federal departments and agencies are focused on developing interest in new assessment projects which are typically funded through a program or grant. Assessments are carried out by expert panels and can be on any topic in areas of health, environment, energy and society, or S&T and innovation.

Seeking funding support for genomics and related sciences research in Canada through the financing of Genome Canada's activities.

Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of physical and digital infrastructure, health workforce, immigration, aging, older adult care, child and youth health, mental health and substance use, palliative care, cybersecurity, Indigenous health, environment, and data. Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.

Support for new research and campus infrastructure. Increased funding and program design for various programs administered by Social Sciences and Humanities Research Council (SSHRC), Natural Sciences and Engineering Research Council (NSERC), and Canadian Institutes of Health Research (CIHR). Funding or support with respect to international development cooperation (student and academic mobility, internships, research collaboration, exchanges, technical assistance). Discussions regarding possible research and development initiatives for, and investments in, partnerships with the University of Calgary. Discussions concerning potential research and development initiatives and investments related to clean energy, environmental research and climate change policy. Discussions about policy implementation regarding the academic visa process in support of international faculty recruitment with respect to changes to the Immigration and Refugee Protection Regulations. Budget bills in support of federal funding for post-secondary education, research, innovation, science and technology.

Seek funding and support for the institution’s teaching, and research and development enterprise in life sciences, basic and applied sciences, social sciences, humanities and fine arts and mental health. Support for the implementation and operation of the Canada Water Agency Support for institutional compliance with federal research security requirements. Seek program development and support for Indigenous-led research Seeking program development for career opportunities for Indigenous post-secondary graduates Seeking greater efficiencies and continued funding of the Canada Student Loan Program Seek funding for international opportunities in student experience through academic exchanges, study abroad and international student visits to Canada Secure funding for Major Science Infrastructure Policy development and research funding for knowledge transfer and the commercialization of research Increase federal funding to the Canada Graduate Scholarship Program and other national initiatives in support of graduate students Funding for research and campus infrastructure Funding for internships, fellowships and student work-integrated learning Facilitation of improved policies that impact international students and other highly qualified personnel Discuss post-secondary institutions' role in securing Canada's water future through education and research. Discuss post-secondary institutions' role in securing Canada's energy future through research and teaching. Development of a national program for the provision of long-term operating funding for major science initiatives like the Canadian Light Source (CLS) and the Vaccine and Infectious Disease Organization (VIDO) Continue and increase funding to the Tri-Agency (CIHR, NSERC, SSHRC) in order to maintain an internationally competitive research and development infrastructure. Continue and increase funding to the Indirect Costs of Research Program in order to maintain an internationally competitive research and development infrastructure Continue and increase funding to the Canada Foundation for Innovation in order to maintain an internationally competitive research and development infrastructure. Budget bills in support of the federal role in post-secondary education, research and the science and technology framework

Federal AI Adoption capability for ISED as a federal department Joint health data proposal together with research hospitals Pan-Canadian AI Compute Environment (PAICE) program progress and AI compute Bill C-27: Artificial Intelligence and Data Act (AIDA) consultation